Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study

Table 4 CCND1 rs9344 and lung cancer risk under the random- and fixed- effects model

Genetic model	Random-effects model					Fixed-effects model					Publication bias (P)
	Test of association			Test of heterogeneity		Test of association			Test of heterogeneity		Publication bias (P)
	OR	95%CI	P	P	I²(%)	OR	95%CI	P	P	I²(%)	Egger’s test	Begg’s test
GA vs. GG	1.02	0.85–1.23	0.847	0.0052	60.10%	1.00	0.9207–1.0957	0.9215	0.01%	60.10%	0.7850	0.3502
AA vs. GG	1.01	0.77–1.32	0.943	< 0.0001	73.10%	1.06	0.9522–1.1727	0.2989	< 0.0001	73.10%	0.6488	1.0000
AA vs. GA	1.00	0.81–1.24	0.983	0.0002	69.90%	1.08	0.9833–1.1788	0.1106	0.0002	69.90%	0.3409	0.2758
AA + GA vs. GG	1.04	0.85–1.26	0.726	0.0005	68.20%	1.06	0.9755–1.1478	0.1735	0.0005	68.20%	0.7651	0.8763
GA vs. AA + GG	1.01	0.86–1.17	0.976	0.0025	63.20%	0.99	0.9175–1.0590	0.6938	0.0025	63.20%	0.7450	0.5334
AA vs. GA + GG	1.00	0.81–1.25	0.942	< 0.0001	73.80%	1.09	0.9977–1.1844	0.0564	< 0.0001	73.80%	0.3367	0.5334
allelic A vs. G	1.02	0.90–1.16	0.757	< 0.0001	73.30%	1.05	1.0005–1.1074	0.0478	< 0.0001	73.30%	0.5028	0.8763

ISSN: 1471-2466